Filing Flows › GoodRx Holdings (GDRX) › Stock forecast & fair value
GoodRx Holdings (GDRX) stock forecast and price target
GoodRx Holdings (GDRX) trades at $3.51. 12 analysts' median price target is $4.00 (+14%), from $2.65 to $5.00.
GoodRx Holdings' latest quarter
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for GDRX stock?
The median of 12 analysts' 12-month targets is $4.00, +14% from $3.51; the range is $2.65 to $5.00. The average rating is hold.
Does GoodRx Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is GDRX stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.